EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Isothiocyanates Potentiate Tazemetostat-Induced Apoptosis by Modulating the Expression of Apoptotic Genes, Members of Polycomb Repressive Complex 2, and Levels of Tri-Methylating Lysine 27 at Histone 3 in Human Malignant Melanoma Cells

Ioannis Anestopoulos iD, Ioannis Paraskevaidis iD, Sotiris Kyriakou iD, Lambrini E Giova, Dimitrios T Trafalis iD, Sotiris Botaitis, Rodrigo Franco iD, Aglaia Pappa iD, Mihalis I Panayiotidis iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25052745 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Ioannis Anestopoulos und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Genetics, Therapeutics & Ultrastructural Pathology, The Cyprus Institute of Neurology & Genetics, 6 Iroon Avenue, Ayios Dometios…. Hauptthemen laut MEDLINE: Histones, Melanoma, Benzamides, Biphenyl Compounds. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hellenic Foundation for Research and Innovation, Cyprus Institute of Neurology and Genetics, OPENSCREEN-GR: An Open-Access Research Infrastructure of Target-Based Screening Technologies and Chemical Biology for Human and Animal Health, Agriculture and….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this study, we utilized an in vitro model consisting of human malignant melanoma as well as non-tumorigenic immortalized keratinocyte cells with the aim of characterizing the therapeutic effectiveness of the clinical epigenetic drug Tazemetostat alone or in combination with various isothiocyanates. In doing so, we assessed markers of cell viability, apoptotic induction, and expression levels of key proteins capable of mediating the therapeutic response. Our data indicated, for the first time, that Tazemetostat caused a significant decrease in viability levels of malignant melanoma cells in a dose- and time-dependent manner via the induction of apoptosis, while non-malignant keratinocytes were more resistant. Moreover, combinatorial treatment protocols caused a further decrease in cell viability, together with higher apoptotic rates. In addition, a significant reduction in the Polycomb Repressive Complex 2 (PRC2) members [e.g., Enhancer of Zeste Homologue 2 (EZH2), Embryonic Ectoderm Development (EED), and suppressor of zeste 12 (SUZ12)] and tri-methylating lysine 27 at Histone 3 (H3K27me3) protein expression levels was observed, at least partially, under specific combinatorial exposure conditions. Reactivation of major apoptotic gene targets was determined at much higher levels in combinatorial treatment protocols than Tazemetostat alone, known to be involved in the induction of intrinsic and extrinsic apoptosis. Overall, we developed an optimized experimental therapeutic platform aiming to ensure the therapeutic effectiveness of Tazemetostat in malignant melanoma while at the same time minimizing toxicity against neighboring non-tumorigenic keratinocyte cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HistonesMelanomaBenzamidesBiphenyl CompoundsMorpholinesPyridonesHumansPolycomb Repressive Complex 2LysineEnhancer of Zeste Homolog 2 ProteinApoptosis

Stichwörter der Autor:innen

Tazemetostatapoptosisepigeneticsisothiocyanatesmelanomatherapeutics

Substanzen

HistonesPolycomb Repressive Complex 2LysinetazemetostatEnhancer of Zeste Homolog 2 ProteinBenzamidesBiphenyl CompoundsMorpholinesPyridones

Autor:innen und Institutionen

  • Department of Cancer Genetics, Therapeutics & Ultrastructural Pathology, The Cyprus Institute of Neurology & Genetics, 6 Iroon Avenue, Ayios Dometios, Nicosia 2371, Cyprus.
  • Laboratory of Pharmacology, Medical School, National & Kapodistrian University of Athens, 11527 Athens, Greece.
  • Department of Surgery, School of Medicine, University Hospital, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
  • School of Veterinary Medicine & Biomedical Sciences, University of Nebraska-Lincoln, Lincoln, NE 68583, USA.
  • Redox Biology Centre, University of Nebraska-Lincoln, Lincoln, NE 68583, USA.
  • Department of Molecular Biology & Genetics, Democritus University of Thrace, 68100 Alexandroupolis, Greece.

ORCID-Profile: Ioannis Anestopoulos, Ioannis Paraskevaidis, Sotiris Kyriakou, Dimitrios T Trafalis, Rodrigo Franco, Aglaia Pappa, Mihalis I Panayiotidis

Förderung

  • Hellenic Foundation for Research and Innovation
  • Cyprus Institute of Neurology and Genetics
  • OPENSCREEN-GR: An Open-Access Research Infrastructure of Target-Based Screening Technologies and Chemical Biology for Human and Animal Health, Agriculture and…
  • Competitiveness, Entrepreneurship and Innovation

Zitieren

APA

Anestopoulos, I., Paraskevaidis, I., Kyriakou, S., Giova, L. E., Trafalis, D. T., Botaitis, S., Franco, R., Pappa, A., & Panayiotidis, M. I. (2024). Isothiocyanates Potentiate Tazemetostat-Induced Apoptosis by Modulating the Expression of Apoptotic Genes, Members of Polycomb Repressive Complex 2, and Levels of Tri-Methylating Lysine 27 at Histone 3 in Human Malignant Melanoma Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25052745

Vancouver

Anestopoulos I, Paraskevaidis I, Kyriakou S, Giova LE, Trafalis DT, Botaitis S, et al. Isothiocyanates Potentiate Tazemetostat-Induced Apoptosis by Modulating the Expression of Apoptotic Genes, Members of Polycomb Repressive Complex 2, and Levels of Tri-Methylating Lysine 27 at Histone 3 in Human Malignant Melanoma Cells. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25052745

BibTeX
@article{Anestopoulos2024,
  author = {Anestopoulos, Ioannis and Paraskevaidis, Ioannis and Kyriakou, Sotiris and Giova, Lambrini E and Trafalis, Dimitrios T and Botaitis, Sotiris and Franco, Rodrigo and Pappa, Aglaia and Panayiotidis, Mihalis I},
  title = {Isothiocyanates Potentiate Tazemetostat-Induced Apoptosis by Modulating the Expression of Apoptotic Genes, Members of Polycomb Repressive Complex 2, and Levels of Tri-Methylating Lysine 27 at Histone 3 in Human Malignant Melanoma Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25052745}
}
Kostenlos starten →